Dr. Vladimir Cmiljanovic Vladimir Cmiljanovic is Co-Founder, Chief Executive Officer, and Vice-Chairman of the Board of Directors of PIQUR. Vladimir has hands-on experience in the range of chemistry disciplines (organic, medicinal, analytical... Vladimir Cmiljanovic is Co-Founder, Chief Executive Officer, and Vice-Chairman of the Board of Directors of PIQUR. Vladimir has hands-on experience in the range of chemistry disciplines (organic, medicinal, analytical & biochemistry) essential to the discovery of PI3K-Akt-mTOR pathway products. Vladimir built up the team of well-known and recognized experts from the field and is leader of the team creating PIQUR's industry leading next generation PI3K agents. For his scientific contribution in PI3K-AKT-mTOR research field he was awarded in 2009 with the Camille and Henry Dreyfus Award of the University of Basel and in 2011 with the Novartis and University of Basel Excellence Scholarship for Life Sciences

Founded in 2011, as a spin-off company of University of Basel (Switzerland), PIQUR Therapeutics AG is a biopharmaceutical company developing best-in-class, next generation cancer therapeutics targeting the PI3K-Akt-mTOR pathway. With its next generation agents, PIQUR is confident that it is the leader in the development of drugs tackling the PI3K cancer pathway.